What is Cardiomyopathies Matter?
Cardiomyopathies Matter is a multi-stakeholder initiative funded by Bristol Myers Squibb that aims to raise awareness of cardiomyopathies among policy-makers and to ensure these health conditions are given the policy attention they warrant both at national and EU levels.
Specifically, the initiative provides a platform for stakeholders to collaborate to:
- inform policymakers about cardiomyopathies and their impact on individuals, societies and healthcare systems
- identify key challenges and unmet needs
- offer policy recommendations to improve patient outcomes, for example by supporting early diagnosis, access to optimal care, and innovation.